SAN DIEGO, Sept. 19 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Amex: HTI - News), a biopharmaceutical company developing and commercializing recombinant human enzymes, today announced that it will present at the Noble Financial Small Cap Conference to be held at the Ballantyne Resort in Charlotte, N.C., on September 26-28, 2006.
